bioRxivBioengineering
DNA origami nanostructures as a tool for the targeted destruction of bacteria
I. Mela, P. P. Vallejo-Ramirez, S. Makarchuk, G. Christie, D. M. D. Bailey, R. M. Henderson, H. Sugiyama, M. Endo, C. F. Kaminski
Abstract
Antibiotic resistance is a growing worldwide human health issue that is now rendering us vulnerable once again to infections that have been treatable for decades. Various approaches have been proposed in an effort to overcome this threat and effectively treat bacterial infections. We use a DNA origami nanostructure, functionalized with aptamers, as a vehicle for delivering the antibacterial peptide lysozyme in a specific and efficient manner, in order to destroy bacterial targets. We test the system against Gram-positive (Bacillus subtilis) and Gram - negative (Escherichia coli) targets. We use direct stochastic optical reconstruction microscopy (dSTORM) and atomic force microscopy (AFM) to characterize the DNA origami nanostructures and structured illumination microscopy (SIM) to assess the binding of origami to the bacteria. We show that treatment with lysozyme-functionalized origami slows bacterial growth more effectively than treatment with free lysozyme. Our study introduces DNA origami as a tool in the fight against antibiotic resistance, and our results demonstrate the specificity and efficiency of the nanostructure as a drug delivery vehicle. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=105 SRC="FIGDIR/small/837252v2_ufig1.gif" ALT="Figure 1"> View larger version (28K): org.highwire.dtl.DTLVardef@1d7d8edorg.highwire.dtl.DTLVardef@1e2eb05org.highwire.dtl.DTLVardef@b3c671org.highwire.dtl.DTLVardef@a93a9e_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: bacteria (other)
- research focus: drug response / drug discovery
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Autonomous treatment of bacterial infections in vivo using antimicrobial micro- and nanomachines
X. Arque, M. D. T. Torres, … C. de la Fuente-Nunez·bioRxiv·Nov 11, 2021
- Spatially Organized DNA-templated Silver Nanoclusters as Potent Antimicrobial Agents for ESKAPE Infections
Elizabeth Skelly, Krishna J. Majithia, … Kirill A. Afonin·bioRxiv·Oct 2, 2025
- Durable Antimicrobial Microstructure Surface (DAMS) Enabled by 3D-Printing and ZnO Nanoflowers
FNU Yuqing, Shuhuan Zhang, … Ke Du·LangmuirPeer-reviewed·Nov 25, 2024
- Ohmline lipid platform: a dual antimicrobial and nanocarrier strategy to potentiate antibiotic efficacy
Diana Marcos Fernandez, Natalia Alfaro, … Axel Hollmann·bioRxiv·Jan 19, 2026
- Decoding Antimicrobial Resistance: Fusing Biologic Acumen and Computational Virtuosity for Paradigmatic Drug Innovation
Revanth Ananthoju, Parvatham Karthik Reddy·Journal of Biology and Health SciencePeer-reviewed·Jan 1, 2025
- A 2.8A structure of zoliflodacin in a DNA-cleavage complex with Staphylococcus aureus DNA gyrase
H. Morgan, M. Lipka-Lloyd, … B. D. Bax·bioRxiv·Nov 30, 2022